Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

ECG Signal as Robust and Reliable Biometric Marker: Datasets and Algorithms Comparison.

Pelc M, Khoma Y, Khoma V.

Sensors (Basel). 2019 May 22;19(10). pii: E2350. doi: 10.3390/s19102350.

2.

PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized Study.

Jarzebicka D, Sieczkowska-Golub J, Kierkus J, Czubkowski P, Kowalczuk-Kryston M, Pelc M, Lebensztejn D, Korczowski B, Socha P, Oracz G.

J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):318-324. doi: 10.1097/MPG.0000000000002192.

PMID:
30383579
3.

Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

Schnute ME, Wennerstål M, Alley J, Bengtsson M, Blinn JR, Bolten CW, Braden T, Bonn T, Carlsson B, Caspers N, Chen M, Choi C, Collis LP, Crouse K, Färnegårdh M, Fennell KF, Fish S, Flick AC, Goos-Nilsson A, Gullberg H, Harris PK, Heasley SE, Hegen M, Hromockyj AE, Hu X, Husman B, Janosik T, Jones P, Kaila N, Kallin E, Kauppi B, Kiefer JR, Knafels J, Koehler K, Kruger L, Kurumbail RG, Kyne RE Jr, Li W, Löfstedt J, Long SA, Menard CA, Mente S, Messing D, Meyers MJ, Napierata L, Nöteberg D, Nuhant P, Pelc MJ, Prinsen MJ, Rhönnstad P, Backström-Rydin E, Sandberg J, Sandström M, Shah F, Sjöberg M, Sundell A, Taylor AP, Thorarensen A, Trujillo JI, Trzupek JD, Unwalla R, Vajdos FF, Weinberg RA, Wood DC, Xing L, Zamaratski E, Zapf CW, Zhao Y, Wilhelmsson A, Berstein G.

J Med Chem. 2018 Dec 13;61(23):10415-10439. doi: 10.1021/acs.jmedchem.8b00392. Epub 2018 Sep 9.

PMID:
30130103
4.

Phenotype expansion and development in Kosaki overgrowth syndrome.

Gawliński P, Pelc M, Ciara E, Jhangiani S, Jurkiewicz E, Gambin T, Różdżyńska-Świątkowska A, Dawidziuk M, Coban-Akdemir ZH, Guilbride DL, Muzny D, Lupski JR, Krajewska-Walasek M.

Clin Genet. 2018 Apr;93(4):919-924. doi: 10.1111/cge.13192.

PMID:
29226947
5.

Novel pathogenic variant in the HRAS gene with lethal outcome and a broad phenotypic spectrum among Polish patients with Costello syndrome.

Pelc M, Ciara E, Jezela-Stanek A, Kugaudo M, Cieślikowska A, Jurkiewicz D, Janeczko M, Chrzanowska K, Krajewska-Walasek M, Skórka A.

Clin Dysmorphol. 2017 Apr;26(2):83-90. doi: 10.1097/MCD.0000000000000165.

PMID:
28027064
6.

Existence of nontrivial topologically protected states at grain boundaries in bilayer graphene: signatures and electrical switching.

Jaskólski W, Pelc M, Chico L, Ayuela A.

Nanoscale. 2016 Mar 21;8(11):6079-84. doi: 10.1039/c5nr08630b.

PMID:
26931739
7.

Recombinant growth hormone therapy in a girl with Costello syndrome: a 4-year observation.

Blachowska E, Petriczko E, Horodnicka-Józwa A, Skórka A, Pelc M, Krajewska-Walasek M, Walczak M.

Ital J Pediatr. 2016 Jan 26;42:10. doi: 10.1186/s13052-015-0209-4.

8.

PHENOTYPIC CONSEQUENCES AND THE MALIGNANCY RISK IN FAMILIAL NOONAN SYNDROME DUE TO A RARE P.S427G RAF1 MUTATION.

Pelc M, Ciara E, Jezela-Stanek A, Krajewska-Walasek M.

Genet Couns. 2016;27(3):325-333.

PMID:
30204961
9.

Oculocutaneous albinism in a patient with 17p13.2-pter duplication - a review on the molecular syndromology of 17p13 duplication.

Kucharczyk M, Jezela-Stanek A, Gieruszczak-Bialek D, Kugaudo M, Cieslikowska A, Pelc M, Krajewska-Walasek M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):333-7. doi: 10.5507/bp.2015.003. Epub 2015 Feb 10.

10.

Is diagnosing cardio-facio-cutaneous (CFC) syndrome still a challenge? Delineation of the phenotype in 15 Polish patients with proven mutations, including novel mutations in the BRAF1 gene.

Ciara E, Pelc M, Jurkiewicz D, Kugaudo M, Gieruszczak-Białek D, Skórka A, Posmyk R, Jakubiuk-Tomaszuk A, Cieślikowska A, Chrzanowska KH, Jezela-Stanek A, Krajewska-Walasek M.

Eur J Med Genet. 2015 Jan;58(1):14-20. doi: 10.1016/j.ejmg.2014.11.002. Epub 2014 Nov 11.

PMID:
25463315
11.

The quality of life of non-small cell lung cancer patients treated with chemotherapy.

Karczmarek-Borowska B, Pelc M, Rabiej E, Grądalska-Lampart M.

Pneumonol Alergol Pol. 2014;82(4):349-57. doi: 10.5603/PiAP.2014.0044.

12.

Spectrum of JAG1 gene mutations in Polish patients with Alagille syndrome.

Jurkiewicz D, Gliwicz D, Ciara E, Gerfen J, Pelc M, Piekutowska-Abramczuk D, Kugaudo M, Chrzanowska K, Spinner NB, Krajewska-Walasek M.

J Appl Genet. 2014 Aug;55(3):329-36. doi: 10.1007/s13353-014-0212-2. Epub 2014 Apr 20.

13.

Octagonal defects at carbon nanotube junctions.

Jaskólski W, Pelc M, Chico L, Ayuela A.

ScientificWorldJournal. 2013 Sep 5;2013:658292. doi: 10.1155/2013/658292. eCollection 2013.

14.

1.15 Mb microdeletion in chromosome band 20p13 associated with moderate developmental delay-additional case and data's review.

Jezela-Stanek A, Kucharczyk M, Pelc M, Gutkowska A, Krajewska-Walasek M.

Am J Med Genet A. 2013 Jan;161A(1):172-8. doi: 10.1002/ajmg.a.35654. Epub 2012 Nov 19. Review.

PMID:
23165892
15.

A girl with two syndromes: Turner syndrome and Costello syndrome. A case history.

Skórka A, Ciara E, Gieruszczak-Białek D, Pelc M, Kugaudo M, Chrzanowska K, Krajewska-Walasek M.

Am J Med Genet A. 2012 Jun;158A(6):1486-8. doi: 10.1002/ajmg.a.35320. Epub 2012 Apr 23. No abstract available.

PMID:
22528320
16.

History and molecular characteristics of a patient with terminal deletion of 14q. Is this another syndrome with a striking phenotype?

Jezela-Stanek A, Kucharczyk M, Gutkowska A, Pelc M, Ciara E, Chrzanowska KH, Krajewska-Walasek M.

Clin Dysmorphol. 2012 Apr;21(2):97-100. doi: 10.1097/MCD.0b013e32834e92b8. No abstract available.

PMID:
22391620
17.

Minimal clinical findings in a patient with 15qter microdeletion syndrome: delineation of the associated phenotype.

Jezela-Stanek A, Kucharczyk M, Pelc M, Chrzanowska KH, Krajewska-Walasek M.

Am J Med Genet A. 2012 Apr;158A(4):922-6. doi: 10.1002/ajmg.a.34440. Epub 2012 Feb 17. No abstract available.

PMID:
22344789
18.

Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.

Meyers MJ, Long SA, Pelc MJ, Wang JL, Bowen SJ, Walker MC, Schweitzer BA, Madsen HM, Tenbrink RE, McDonald J, Smith SE, Foltin S, Beidler D, Thorarensen A.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6538-44. doi: 10.1016/j.bmcl.2011.08.055. Epub 2011 Aug 22.

PMID:
21924614
19.

Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.

Meyers MJ, Long SA, Pelc MJ, Wang JL, Bowen SJ, Schweitzer BA, Wilcox MV, McDonald J, Smith SE, Foltin S, Rumsey J, Yang YS, Walker MC, Kamtekar S, Beidler D, Thorarensen A.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6545-53. doi: 10.1016/j.bmcl.2011.08.048. Epub 2011 Aug 19.

PMID:
21924613
20.

Cryptic x; autosome translocation in a boy--delineation of the phenotype.

Jezela-Stanek A, Ciara E, Juszczak M, Pelc M, Materna-Kiryluk A, Krajewska-Walasek M.

Pediatr Neurol. 2011 Mar;44(3):221-4. doi: 10.1016/j.pediatrneurol.2010.10.007.

PMID:
21310340
21.

Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS).

Carron CP, Trujillo JI, Olson KL, Huang W, Hamper BC, Dice T, Neal BE, Pelc MJ, Day JE, Rohrer DC, Kiefer JR, Moon JB, Schweitzer BA, Blake TD, Turner SR, Woerndle R, Case BL, Bono CP, Dilworth VM, Funckes-Shippy CL, Hood BL, Jerome GM, Kornmeier CM, Radabaugh MR, Williams ML, Davies MS, Wegner CD, Welsch DJ, Abraham WM, Warren CJ, Dowty ME, Hua F, Zutshi A, Yang JZ, Thorarensen A.

ACS Med Chem Lett. 2010 Feb 2;1(2):59-63. doi: 10.1021/ml900025z. eCollection 2010 May 13.

22.

A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.

Gierse J, Thorarensen A, Beltey K, Bradshaw-Pierce E, Cortes-Burgos L, Hall T, Johnston A, Murphy M, Nemirovskiy O, Ogawa S, Pegg L, Pelc M, Prinsen M, Schnute M, Wendling J, Wene S, Weinberg R, Wittwer A, Zweifel B, Masferrer J.

J Pharmacol Exp Ther. 2010 Jul;334(1):310-7. doi: 10.1124/jpet.110.165845. Epub 2010 Apr 14.

PMID:
20392816
23.

Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode.

Meyers MJ, Pelc M, Kamtekar S, Day J, Poda GI, Hall MK, Michener ML, Reitz BA, Mathis KJ, Pierce BS, Parikh MD, Mischke DA, Long SA, Parlow JJ, Anderson DR, Thorarensen A.

Bioorg Med Chem Lett. 2010 Mar 1;20(5):1543-7. doi: 10.1016/j.bmcl.2010.01.078. Epub 2010 Jan 21.

PMID:
20137931
24.

Structure based design of novel irreversible FAAH inhibitors.

Wang JL, Bowen SJ, Schweitzer BA, Madsen HM, McDonald J, Pelc MJ, Tenbrink RE, Beidler D, Thorarensen A.

Bioorg Med Chem Lett. 2009 Oct 15;19(20):5970-4. doi: 10.1016/j.bmcl.2009.07.101. Epub 2009 Jul 25.

PMID:
19765986
25.

An approach to the imine ring system of pinnatoxins.

Pelc MJ, Zakarian A.

Org Lett. 2005 Apr 14;7(8):1629-31.

PMID:
15816769
26.

Local jamming via penetration of a granular medium.

Stone MB, Barry R, Bernstein DP, Pelc MD, Tsui YK, Schiffer P.

Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Oct;70(4 Pt 1):041301. Epub 2004 Oct 29.

PMID:
15600401
27.

Stress propagation: getting to the bottom of a granular medium.

Stone MB, Bernstein DP, Barry R, Pelc MD, Tsui YK, Schiffer P.

Nature. 2004 Feb 5;427(6974):503-4.

PMID:
14765185
28.

Case report: ingestion of an air-water syringe tip.

Pinkney HS, Greenbaum JB, Pelc M.

J Mich Dent Assoc. 1995 Oct;77(8):38-9. No abstract available.

PMID:
9508910
29.

The civil right to speech.

Pelc M.

ASHA. 1993 May;35(5):7. No abstract available.

PMID:
8318053
30.

[Dentition of workers of the salt mines in Wieliczka].

Knychalska-Karwan Z, Biedowa J, Gawrzewska B, Kaczmarczyk-Stachowska A, Laskowska L, Pelc M, Szafraniec I, Wedler A.

Czas Stomatol. 1973 Dec;26(12):1291-5. Polish. No abstract available.

PMID:
4148749
31.

[The index of oral hygiene (OHI) and the periodontal index of Russell in periodontal diseases in salt mine workers in Wieliczka].

Bieda J, Gawrzewska B, Kaczmarczyk-Stachowska A, Knychalska-Karwan Z, Laskowska L, Pelc M, Szafraniec I, Wedler A.

Czas Stomatol. 1968 Oct;21(10):1277-81. Polish. No abstract available.

PMID:
5247326
32.

[The incidence of periodontal diseases in salt mine workers in Wieliczka].

Bieda J, Gawrzewska B, Kaczmarczyk-Stachowska A, Knychalska-Karwan Z, Laskowska L, Pelc M, Szafraniec I, Wedler A.

Czas Stomatol. 1968 Oct;21(10):1271-6. Polish. No abstract available.

PMID:
5246730
33.

[Pathological changes in the oral mucosa in workers of the Wieliczka Salt Mines].

Bieda J, Gawrzewska B, Kaczmarczyk-Stachowska A, Knychalska-Karwan Z, Laskowska L, Pelc M, Szafraniec I, Wedler A.

Czas Stomatol. 1968 Aug;21(8):919-25. Polish. No abstract available.

PMID:
5245398
34.

[Cytological picture of the buccal mucosa in workers in the Wieliczka Salt Mines].

Knychalska-Karwan Z, Szafraniec I, Bieda J, Gawrzewska B, Kaczmarczyk-Stachowska A, Laskowska L, Pelc M, Wedler A.

Czas Stomatol. 1968 Aug;21(8):927-33. Polish. No abstract available.

PMID:
4175912
35.

[Evaluation of Ramfjord's oral health and periodontal PDI indices in children at Luborzyca].

Knychalska-Karwan Z, Laskowska L, Pelc M, Szafraniec I, Wedler A.

Czas Stomatol. 1968 Jan;21(1):85-92. Polish. No abstract available.

PMID:
5240385
36.

[Thrombin preparation produced by the Krakow regional blood-donor station and its applications].

PELC M.

Pol Przegl Chir. 1959 Apr;31:423-5. Polish. No abstract available.

PMID:
14431434
37.

[Venous pressure & circulation time in the course of burns].

PELC M.

Pol Tyg Lek (Wars). 1958 Aug 11;13(32):1241-3. Polish. No abstract available.

PMID:
13613985
38.

[Behavior of venous pressure during chest surgery].

JUSZCZYNSKI M, CYBULSKI L, PELC M, KROL W.

Pol Tyg Lek (Wars). 1957 Mar 11;12(11):389-91. Polish. No abstract available.

PMID:
13452927
39.

[Behavior of venous tension in surgical patients before, during, and in the first few days after surgery].

KROL W, CYBULSKI L, PELC M, JUSZCZYNSKI M.

Pol Tyg Lek (Wars). 1957 Jan 21;12(4):136-40. Polish. No abstract available.

PMID:
13431531
40.

[Determination of rate of blood circulation in surgical diseases].

PELC M.

Przegl Lek. 1954 Dec;10(12a):370-5. Polish. No abstract available.

PMID:
14371815

Supplemental Content

Support Center